Savings Under Most-Favored-Nation Pricing for Prescription Drugs in Medicaid
This study compares current Medicaid rebates with international reference prices and estimated potential savings under the Generating Cost Reductions for US Medicaid payment model.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.